CDC awards Micron research contract to develop a patch for co-administration of IRV and IPV

ATLANTA, September 1, 2016 – Micron Biomedical, Inc. signs a research contract with the Centers for Disease Control and Prevention (CDC) to fund the development of a dissolving microneedle patch for the co-administration of inactivated rotavirus vaccine (IRV) and inactivated polio vaccine (IPV).  The goals of the contract are the design and development of an optimal formulation to combine IRV and IPV in a microneedle patch and fabrication of IRV-IPV microneedle patches for pre-clinical evaluation. According to the CDC, a combined IRV-IPV microneedle patch will not only improve vaccine performance over currently licensed oral rotavirus vaccines, but also help conduct house-to-house immunization campaigns in the post-oral polio vaccine era, thus sustaining efforts to eradicate polio.